SE9603461D0 - New compounds - Google Patents
New compoundsInfo
- Publication number
- SE9603461D0 SE9603461D0 SE9603461A SE9603461A SE9603461D0 SE 9603461 D0 SE9603461 D0 SE 9603461D0 SE 9603461 A SE9603461 A SE 9603461A SE 9603461 A SE9603461 A SE 9603461A SE 9603461 D0 SE9603461 D0 SE 9603461D0
- Authority
- SE
- Sweden
- Prior art keywords
- formula
- variable
- amino acid
- description
- meaning defined
- Prior art date
Links
Abstract
Physiologically active peptides of formula (I) A-R1-R2-R3-(R4)x-B wherein each variable has the meaning defined in the description, at least one of R1, R2 and R3 being R8 and at most one of R1, R2 and R3 being cysteine; and R8 is an amino acid residue of formula (II) or formula (III), wherein each variable has the meaning defined in the description, the entire peptide sequence containing 3 to 30 amino acid residues. These peptides are absorbable by the epithelial cell lining in a mammal resulting in a modulated immune response and thereby a therapeutic effect against disease.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9603461A SE9603461D0 (en) | 1996-09-23 | 1996-09-23 | New compounds |
PCT/SE1997/001548 WO1998012214A1 (en) | 1996-09-23 | 1997-09-15 | Cysteine analogue containing peptides having immunomodulatory effect |
AU44059/97A AU4405997A (en) | 1996-09-23 | 1997-09-15 | Cysteine analogue containing peptides having immunomodulatory effect |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9603461A SE9603461D0 (en) | 1996-09-23 | 1996-09-23 | New compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9603461D0 true SE9603461D0 (en) | 1996-09-23 |
Family
ID=20403983
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9603461A SE9603461D0 (en) | 1996-09-23 | 1996-09-23 | New compounds |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU4405997A (en) |
SE (1) | SE9603461D0 (en) |
WO (1) | WO1998012214A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10973920B2 (en) | 2014-06-30 | 2021-04-13 | Glykos Finland Oy | Saccharide derivative of a toxic payload and antibody conjugates thereof |
EP3464336B1 (en) | 2016-06-01 | 2022-03-16 | Athira Pharma, Inc. | Compounds |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1366088A (en) * | 1987-01-28 | 1988-08-24 | Ortho Pharmaceutical Corporation | Immunosuppressive peptides and methods of use |
DE3841759A1 (en) * | 1988-12-12 | 1990-06-13 | Basf Ag | NEW TNF PEPTIDES |
CA2045578A1 (en) * | 1989-01-31 | 1990-08-01 | Megumi Kawai | Anaphylatoxin-receptor ligands |
US5137873A (en) * | 1990-07-27 | 1992-08-11 | The Children's Medical Center Corporation | Substance p and tachykinin agonists for treatment of alzheimer's disease |
US5753617A (en) * | 1992-09-08 | 1998-05-19 | Centocor, Inc. | Peptide inhibitors of cellular adhesion |
SE9403526D0 (en) * | 1994-10-14 | 1994-10-14 | Astra Ab | New Peptides |
-
1996
- 1996-09-23 SE SE9603461A patent/SE9603461D0/en unknown
-
1997
- 1997-09-15 AU AU44059/97A patent/AU4405997A/en not_active Abandoned
- 1997-09-15 WO PCT/SE1997/001548 patent/WO1998012214A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1998012214A1 (en) | 1998-03-26 |
AU4405997A (en) | 1998-04-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69126568T2 (en) | New physiologically active pig peptide (CNP-53) | |
DK1188768T3 (en) | LHRH antagonist peptides | |
LV10720A (en) | Peptides and pharmaceutical compositions on their bases | |
DK0966297T3 (en) | Regulation of gastrointestinal motility | |
ES2229045T3 (en) | DERIVATIVES OF THERAPEUTIC PEPTIDES. | |
TR199802534T2 (en) | Leptin (OB Protein) fragmanlar� | |
KR910700062A (en) | Deletion homologues of marganine peptides | |
SE9603468D0 (en) | New compounds | |
ES2081817T3 (en) | POLYPEPTIDE WITH MAIN SEQUENCES REPEATED THAT ARE FIXED IN THE CELL. | |
DE68917837T2 (en) | Peptide compounds. | |
KR960702754A (en) | VAGINAL PREPARATION CONTAINING PHYSIOLOGICALLY ACTIVE PEPTIDE containing physiologically active peptides | |
DK403789A (en) | A NEW ANTIBIOTIC, MERSACIDIN, ITS PREPARATION AND USE AS A MEDICINE | |
ATE242202T1 (en) | PEPTIDES | |
SE9501067D0 (en) | New peptides | |
SE9603461D0 (en) | New compounds | |
DK1154786T3 (en) | Compositions for modulating mucus secretion | |
ATE42308T1 (en) | PHARMACOLOGICALLY ACTIVE PEPTIDES. | |
FI971427A0 (en) | Peptides and pharmaceutical compositions containing them | |
SE9603463D0 (en) | New compounds | |
SE9603466D0 (en) | New compounds | |
SE9603462D0 (en) | New compounds | |
IT1241003B (en) | PROCEDURE FOR THE PURIFICATION OF AN EQUIVALENT RECOMBINING POLYPEPTIDE HDIV, EQUIVALENT POLYPEPTIDE HDAG AND IMMUNOLOGICAL TESTS USING IT | |
YU2394A (en) | LIZINE SO 6-CHLORO-5-FLUORO-3 - (- 2-TENOIL) -2-OXINDOL-1-CARBOXIDE | |
DE3682368D1 (en) | MITOGENIC PEPTIDES. | |
ES2091571T3 (en) | NEW ACTIVE PEPTIDIC DERIVATIVES IN THE CELL ADHESION PROCESSES, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. |